Contemporary neuroscience continues to harness EE as a powerful non-pharmacological intervention, enhancing hippocampal neurogenesis and reducing anxiety in rodents (Khalil, 2024), reinstating young cortical plasticity in adult animals (Baroncelli et al., 2010), mediating the rescue of visual functions in adult amblyopia (Sale et al., 2007), promoting favorable memory-related brain activity in older adults (Khalil, 2024), and supporting developmental and behavioral gains in infants at risk for cerebral palsy (Zhou et al., 2025) and autism spectrum disorder populations (Hernndez-Arteaga et al., 2025)
Alteration of fatty acid oxidation in tubular epithelial cells: from acute kidney injury to renal fibrogenesis
Just keep in mind that eligibility is just the beginning
In the case of oral GLP-1 treatments, the factors known to complicate the process of establishing the optimal dosing regimen include: Bioavailability Taken orally, GLP-1 receptor agonists are exposed to significant acid in the stomach, resulting in enzymatic degradation
Rohdewald, P